InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities
Precision health leader adds Coriell’s pharmacogenomics capabilities to expand the application of genomics and increase patient access to more personalized and effective health care St. Petersburg, FL – March 19, 2025 – InformedDNA®, a precision health company revolutionizing the application of genomic insights, today announced the acquisition of Coriell Life Sciences, a provider of pharmacogenomic services […]
The Cancer Letter: NCCN publishes patient resource on genetic testing to guide patient decisionmaking
The National Comprehensive Cancer Network published its first patient resource aimed at informing people about the latest recommendations around hereditary and familial cancer risk. Eleanor Riggs, manager of clinical content at InformedDNA, spoke with The Cancer Letter about the value of the new guide and the growing role of genetics in oncology treatments.
ALM Benefits Pro: Will Wegovy help that worker lose weight?
New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar. Two health technology startups have an idea for treating obesity: Use genetic tests and other tests to see whether expensive weight-loss drugs will help obese people much before giving them the…
Press Release: Phenomix Sciences and InformedDNA Partner to Advance Genetics-Driven Obesity Care
Launching at HLTH 2024, the groundbreaking partnership offers payers, health systems, employers, and life science organizations access to personalized obesity care and treatment planning based on a patient’s DNA…
The Cancer Letter: Joint byline, ‘Is gastrectomy indicated?’
A study recently published in JAMA sheds light on cancer risks associated with carrying germline CDH1 mutations, challenging previous, potentially inflated, lifetime cancer risk estimates. InformedDNA, FORCE: Facing Our Risk of Cancer Empowered, and No Stomach For Cancer, collaborate as patient advocates, educators, and experts to support individuals and families impacted by gastric cancer to help them navigate this complex genetic landscape. Subscribers to The Cancer Letter can login to read the full article.
Life Sciences Review: InformedDNA Featured Cover Story, Genetic Testing Edition
Actionable Genomic Insights for Successful Clinical Trials: A powerful genomic force is behind the growing success of clinical trials for drug development of rare diseases. InformedDNA CEO, Dr. Surya Singh shares their winning strategy, powered by their remote genetic experts and deep insights, that boosts accurate patient enrollment, improves retention rates, and empowers informed decision-making for life science clients.
The Cancer Letter: Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists
In a guest byline published in The Cancer Letter, InformedDNA’s chief medical officer and co-founder, Dr. Rebecca Sutphen describes the importance of paired tumor-germline testing in cancer patients and the critical role of genetics specialists in enhancing that care. Subscribers to The Cancer Letter can login to read the full article.
Foundation Fighting Blindness Partners with Prevention Genetics and InformedDNA to Advance My Retina Tracker® Genetic Testing Program
Empowering Healthcare Providers and Patients with Genetic Testing and Genetic Counseling Solutions COLUMBIA, Md., May 15, 2024 /PRNewswire/ — The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, announces today its partnership with PreventionGenetics, a part of Exact Sciences, as its new genetic laboratory partner for […]
Industry Veteran Suggests Broader Genomics Use for Proactive Approach to Health Care
Reprinted with AIS Health permission from the January 2024 issue of Radar on Specialty Pharmacy Tremendous strides have been made in personalized medicine over the past several years — not only in drugs but in the various biomarkers used to identify the right drug for the right patient at the right time. While many people […]
Hereditary Neuropathy Foundation Partners with InformedDNA® on CMT Genie Project
NEW YORK, NEW YORK , UNITED STATES, January 10, 2024 /EINPresswire.com/ — In partnership with InformedDNA® , the Hereditary Neuropathy Foundation (HNF) has added more value to their Charcot-Marie-Tooth (CMT) Genie Project — a patient-initiated at-home CMT genetic testing program, providing faster and more equitable access to critical genetic care for the CMT community and […]
